Randomized controlled trial comparing carbetocin, misoprostol, and oxytocin for the prevention of postpartum hemorrhage following an elective cesarean delivery. (يفتح نافذة جديدة)

Elbohoty AE, Mohammed WE, Sweed M, Bahaa Eldin AM, Nabhan A, Abd-El-Maeboud KH.

Source‎: Int J Gynaecol Obstet 2016;134(3):324-8.

مفهرسة‎: PubMed 27350226

https://www.ncbi.nlm.nih.gov/pubmed/27350226 (يفتح نافذة جديدة)

Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis. (يفتح نافذة جديدة)

Gallos ID, Williams HM, Price MJ, Merriel A, Gee H, Lissauer D, Moorthy V, Tobias A, Deeks JJ, Widmer M, Tunçalp Ö, Gulmezoglu AM, Hofmeyr GJ, Coomarasamy A

Source‎: Cochrane Database Syst Rev 2018;4:CD011689.

مفهرسة‎: PubMed 29693726

DOI‎: 10.1002/14651858.CD011689.pub2

https://www.ncbi.nlm.nih.gov/pubmed/29693726 (يفتح نافذة جديدة)

Preventing postpartum hemorrhage after cesarean delivery: A network meta-analysis of available pharmacologic agents. (يفتح نافذة جديدة)

Jaffer D, Singh PM, Aslam A, Cahill AG, Palanisamy A, Monks DT

Source‎: Am J Obstet Gynecol.

مفهرسة‎: PubMed 34534498

DOI‎: 10.1016/j.ajog.2021.08.060

https://pubmed.ncbi.nlm.nih.gov/34534498/ (يفتح نافذة جديدة)

A randomised controlled trial comparing oxytocin and oxytocin + ergometrine for prevention of postpartum haemorrhage at caesarean section. (يفتح نافذة جديدة)

Koen S, Snyman LC, Pattinson RC, Makin JA.

Source‎: S Afr Med J 2016;106(4):399-402.

مفهرسة‎: PubMed 27032858

https://www.ncbi.nlm.nih.gov/pubmed/27032858 (يفتح نافذة جديدة)

Prophylactic use of ergot alkaloids in the third stage of labour. (يفتح نافذة جديدة)

Liabsuetrakul T, Choobun T, Peeyananjarassri K, Islam QM.

Source‎: Cochrane Database Syst Rev 2007;(2):CD005456.

مفهرسة‎: PubMed 17443592

https://www.ncbi.nlm.nih.gov/pubmed/17443592 (يفتح نافذة جديدة)

Treatment for primary postpartum haemorrhage. (يفتح نافذة جديدة)

Mousa HA, Blum J, Abou El Senoun G, Shakur H, Alfirevic Z.

Source‎: Cochrane Database Syst Rev 2014;(2):CD003249.

مفهرسة‎: PubMed 24523225

https://www.ncbi.nlm.nih.gov/pubmed/24523225 (يفتح نافذة جديدة)

Comparison of two oxytocin regimens to prevent uterine atony at cesarean delivery: a randomized controlled trial. (يفتح نافذة جديدة)

Munn MB, Owen J, Vincent R, Wakefield M, Chestnut DH, Hauth JC.

Source‎: Obstet Gynecol 2001;98(3):386-90.

مفهرسة‎: PubMed 11530117

https://www.ncbi.nlm.nih.gov/pubmed/11530117 (يفتح نافذة جديدة)

Prospective randomized trial of oxytocin administration for active management of the third stage of labor. (يفتح نافذة جديدة)

Oguz Orhan E, Dilbaz B, Aksakal SE, Altınbas S, Erkaya S.

Source‎: Int J Gynaecol Obstet 2014;127(2):175-9.

مفهرسة‎: PubMed 25108586

https://www.ncbi.nlm.nih.gov/pubmed/25108586 (يفتح نافذة جديدة)

A randomized clinical trial of preoperative versus postoperative misoprostol in elective cesarean delivery. (يفتح نافذة جديدة)

Ragab A, Barakat R, Alsammani MA.

Source‎: Int J Gynaecol Obstet 2016;132(1):82-4.

مفهرسة‎: PubMed 26522140

DOI‎: 10.1016/j.ijgo.2015.06.057

https://www.ncbi.nlm.nih.gov/pubmed/26522140 (يفتح نافذة جديدة)

Dose and duration of oxytocin to prevent postpartum hemorrhage: a review. (يفتح نافذة جديدة)

Roach MK, Abramovici A, Tita AT.

Source‎: Am J Perinatol 2013;30(7):523-8.

مفهرسة‎: PubMed 23208766

https://www.ncbi.nlm.nih.gov/pubmed/23208766 (يفتح نافذة جديدة)

Prostaglandin E2 analogue sulprostone for treatment of atonic postpartum hemorrhage. (يفتح نافذة جديدة)

Schmitz T, Tararbit K, Dupont C, Rudigoz RC, Bouvier-Colle MH, Deneux-Tharaux C; Pithagore6 Group.

Source‎: Obstet Gynecol 2011;118(2 Pt 1):257-65.

مفهرسة‎: PubMed 21775840

DOI‎: 10.1097/AOG.0b013e3182255335

https://www.ncbi.nlm.nih.gov/pubmed/21775840 (يفتح نافذة جديدة)

The effects of a peripartum strategy to prevent and treat primary postpartum haemorrhage at health facilities in Niger: a longitudinal, 72-month study. (يفتح نافذة جديدة)

Seim AR, Alassoum Z, Souley I, Bronzan R, Mounkaila A, Ahmed LA

Source‎: Lancet Glob Health. 2023 11(2):e287-e295.

مفهرسة‎: PubMed 36669809

DOI‎: 10.1016/S2214-109X(22)00518-6.

https://pubmed.ncbi.nlm.nih.gov/36669809/ (يفتح نافذة جديدة)

Intravenous sulprostone infusion in the treatment of retained placenta. (يفتح نافذة جديدة)

Stefanovic V, Paavonen J, Loukovaara M, Halmesmäki E, Ahonen J, Tikkanen M.

Source‎: Acta Obstet Gynecol Scand 2013;92(4):426-32.

مفهرسة‎: PubMed 22862433

DOI‎: 10.1111/j.1600-0412.2012.01506.x

https://www.ncbi.nlm.nih.gov/pubmed/22862433 (يفتح نافذة جديدة)

Carbetocin for preventing postpartum haemorrhage. (يفتح نافذة جديدة)

Su LL, Chong YS, Samuel M.

Source‎: Cochrane Database Syst Rev 2012;(4):CD005457.

مفهرسة‎: PubMed 22513931

https://www.ncbi.nlm.nih.gov/pubmed/22513931 (يفتح نافذة جديدة)

Prostaglandins for preventing postpartum haemorrhage. (يفتح نافذة جديدة)

Tunçalp Ö, Hofmeyr GJ, Gülmezoglu AM.

Source‎: Cochrane Database Syst Rev 2012;(8):CD000494.

مفهرسة‎: PubMed 22895917

DOI‎: 10.1002/14651858.CD000494.pub4

https://www.ncbi.nlm.nih.gov/pubmed/22895917 (يفتح نافذة جديدة)

Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage. (يفتح نافذة جديدة)

Westhoff G, Cotter AM, Tolosa JE.

Source‎: Cochrane Database Syst Rev 2013;(10):CD001808.

مفهرسة‎: PubMed 24173606

DOI‎: 10.1002/14651858.CD001808.pub2

https://www.ncbi.nlm.nih.gov/pubmed/24173606 (يفتح نافذة جديدة)